NUCLEOFECTION
Live / Registered — International registration cancelled — extension of protection cancelled (as of 02 Apr 2018)
What this means for you
Registered since 05 Oct 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79065366
- Registration number
- 3856843
- Mark type
- Stylized text
- Filed
- 01 Apr 2008
- Published for opposition
- 20 Jul 2010
- Registered
- 05 Oct 2010
- Attorney of record
- David M. Perry
Goods and services
- Class 001 — Chemicals: Chemical and biochemical preparations used in industry and science for the transfer for biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; buffer and standard solutions for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells for scientific and research use; biological agents, namely, buffer and standard solutions containing living cells, proteins, peptides and nucleic acids for laboratory use other than for medical and veterinary purposes; diagnostic preparations other than for medical and veterinary purposes; biological reagents for laboratories, namely, peptides, proteins, nucleic acids and complexes made of peptides, proteins and nucleic acids, for detecting gene expression and localizing proteins as well as for integrating foreign nucleic acids into the genome of living cells for laboratory use, included in this class
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use; living cells for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; cultures of micro-organisms for medical or clinical use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; proteins, peptides, nucleic acid sequences and biochemical reagents of these molecules for medical and veterinary use in the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer
- Class 009 — Scientific and electric apparatus: Scientific apparatus and instruments, namely, electrical equipment in the nature of electrical field generators and capacitor impulse generators for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; apparatus and instruments for electroporation, namely, electroporators and their peripheral equipment; apparatus and instruments for conducting, switching, converting, storing, controlling and monitoring of electricity, namely, electrical capacitors, electrical conductors and electric parameter monitor modules; laboratory equipment and supplies, namely, containers and reaction vessels of the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; test tubes; electrodes made of metal and conductive polymers; plastic tubes for scientific purposes, namely, laboratory storage tubes; cuvettes, namely, test tubes having electrodes made of metal and conductive polymers for biochemical purposes; multi-well plates having electrodes made of metal and conductive polymers for biochemical purposes; data processors and computers; computer peripherals; computer programs and software recorded on data media designed for use in controlling of scientific apparatus and instruments for the transfer of biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells, as far as included in this class
Owner
- Lonza Cologne GmbH, 50829 Köln, DE
- Lonza Cologne AG, Köln, DE
- Lonza Cologne AG, Köln, DE
- amaxa AG, 50829 Köln, DE
Prior registrations
Prosecution history
- 02 Dec 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 14 Feb 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Aug 2019 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Apr 2019 — REFUSAL PROCESSED BY IB
- 26 Oct 2018 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
- 26 Oct 2018 — DEATH OF INTERNATIONAL REGISTRATION
- 23 Feb 2018 — TOTAL INVALIDATION PROCESSED BY THE IB
- 25 Jan 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 25 Jan 2018 — INVALIDATION PROCESSED
- 12 Jan 2018 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 12 May 2017 — CANCELLED SECTION 71
- 05 Oct 2015 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Jun 2015 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Feb 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Jan 2013 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED